BioMarin Pharmaceutical Inc. (BMRN) Thursday reported a wider first-quarter net loss of $39.8 million or $0.31 per share, wider than $24.0 million or $0.21 per share in the comparable quarter last year.
On average, 18 analysts polled by Thomson Reuters expected the company to lose $0.29 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues for the quarter grew to $127.9 million from $116.6 million last year, while 17 analysts estimated revenues of $131.44 million for the quarter.
For comments and feedback: editorial@rttnews.com